Search Results - "POCH, E"

Refine Results
  1. 1

    Acute tubulointerstitial nephritis associated with atezolizumab, an anti-programmed death-ligand 1 (pd-l1) antibody therapy by Xipell, M, Victoria, I, Hoffmann, V, Villarreal, J, García-Herrera, A, Reig, O, Rodas, L, Blasco, M, Poch, E, Mellado, B, Quintana, L F

    Published in Oncoimmunology (01-01-2018)
    “…Direct stimulation of the antitumor activity of immune system through checkpoint inhibitors (ICIs) has demonstrated efficacy in the treatment of different…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Urinary albumin excretion is associated with true resistant hypertension by Oliveras, A, Armario, P, Hernández-del Rey, R, Arroyo, J A, Poch, E, Larrousse, M, Roca-Cusachs, À, de la Sierra, A

    Published in Journal of human hypertension (01-01-2010)
    “…Resistant (or refractory) hypertension (RH) is a clinical diagnosis based on blood pressure (BP) office measurements. About one third of subjects with…”
    Get full text
    Journal Article
  5. 5

    Bortezomib decreases Rb phosphorylation and induces caspase-dependent apoptosis in Imatinib-sensitive and -resistant Bcr-Abl1-expressing cells by Albero, M P, Vaquer, J M, Andreu, E J, Villanueva, J J, Franch, L, Ivorra, C, Poch, E, Agirre, X, Prosper, F, Pérez-Roger, I

    Published in Oncogene (03-06-2010)
    “…The use of c-abl- specific inhibitors such as Imatinib (IM) or Dasatinib has revolutionized the treatment of chronic myeloid leukemia (CML). However, a…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor by Moreno‐Romero, J.A., Segura, S., Mascaró, J.M., Cowper, S.E., Julià, M., Poch, E., Botey, A., Herrero, C.

    Published in British journal of dermatology (1951) (01-10-2007)
    “…Summary Nephrogenic systemic fibrosis (NSF) or nephrogenic fibrosing dermopathy is a rare fibrotic condition that presents in patients with a history of renal…”
    Get full text
    Journal Article
  9. 9
  10. 10

    A coding polymorphism in the 12-lipoxygenase gene is associated to essential hypertension and urinary 12(S)-HETE by Quintana, L.F., Guzmán, B., Collado, S., Clària, J., Poch, E.

    Published in Kidney international (01-02-2006)
    “…The arachidonic acid-derived metabolite 12-(S)hydroxyeicosatetraenoic acid (12(S)-HETE), catalyzed by 12-lipoxygenase (12-LOX, ALOX12), exhibits a variety of…”
    Get full text
    Journal Article
  11. 11

    RhoE is spatiotemporally regulated in the postnatal mouse CNS by Ballester-Lurbe, B, Poch, E, Mocholí, E, Guasch, R.M, Pérez-Roger, I, Terrado, J

    Published in Neuroscience (06-10-2009)
    “…Abstract Rnd proteins are a family of small GTPases that have been involved in axon path finding and CNS development by their control of actin cytoskeleton…”
    Get full text
    Journal Article
  12. 12
  13. 13

    An update on tolvaptan for autosomal dominant polycystic kidney disease by Poch, E, Rodas, L, Blasco, M, Molina, A, Quintana, L

    Published in Drugs of today (Barcelona, Spain : 1998) (01-09-2018)
    “…Tolvaptan is an orally active antagonist of vasopressin (antidiuretic hormone [ADH]) V2 receptors. By blocking water reabsorption in kidney collecting ducts,…”
    Get full text
    Journal Article
  14. 14

    Endoscopic techniques in bronchogenic carcinoma. Changes in recent decades by García Luján, R, Hisado Díaz, M D, Miguel Poch, E, Alfaro Abreu, J

    Published in Revista clínica espanõla (01-10-2010)
    “…A 57-year old woman with arterial hypertension under treatment. She has smoked since she was 18 years old with an accumulated index of 70 years/pack. She was…”
    Get more information
    Journal Article
  15. 15

    Factors associated with blood pressure control in diabetic patients treated in nephrology units. PRESDIAB Study by Serra, N, Oliveras, A, Bergoñon, S, Sans, L, Cobos, A, Martínez, P, Artigas, R, Poch, E

    “…Most hypertensive patients do not reach target blood pressure (BP), especially if they are diabetic. The objective of the study is to assess the percentage of…”
    Get more information
    Journal Article
  16. 16

    Quality indicators in Hypertension Care Units: indicators of structure in the QUALIHTA study by Poch, E, Felip, A, Davins, J, Coca, A

    Published in Revista clínica espanõla (01-12-2006)
    “…To evaluate the minimum-required indicators of quality of care in Hypertension Units at two levels of delivered care (secondary and tertiary) in Spain. A total…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19

    Hypertension in hemodialysis: prevalence and associated factors in Catalonia. The PRESDIAL study by Poch, E, Martinez, X, Rodrigo, J A, Tovar, J L

    Published in Nefrología (2006)
    “…To evaluate the prevalence of hypertension (HT) in prevalent hemodialysis (HD) patients in our region, and to analyze the associated clinical and biochemical…”
    Get full text
    Journal Article
  20. 20

    Profitability of the bronchoscopy in the diagnosis of focal pulmonary malignant lesions by García Quero, C, García Luján, R, González Torralba, F, de Miguel Poch, E, Alfaro Abreu, J, Villena Garrido, V, López Ríos, F, López Encuentra, A

    Published in Revista clínica espanõla (01-12-2008)
    “…We define focal pulmonary lesion (FPL) as an intra-parenchymatous pulmonary lesion that is well circumscribed and completely surrounded by healthy lung. It is…”
    Get more information
    Journal Article